Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Call Audra Foster, N.D
Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
It is studied in preclinical and laboratory models for its ability to activate target pathways and modulate downstream molecular signaling associated with endocrine regulation
Protein-rich foods support skin regeneration and collagen production
These remain active research areas
View all FAQs Important safety information and common side effects The most commonly reported side effect is irritation of the area where the injection is administered. If this occurs, consider changing placement on the body or use injections less often
US$ 24.71
US$ 21.17
US$ 25.13
US$ 22.01
US$ 22.68
US$ 28.64
